ISEC Healthcare Ltd. (SGX: 40T)
Singapore
· Delayed Price · Currency is SGD
0.395
0.00 (0.00%)
At close: Nov 12, 2024
ISEC Healthcare Income Statement
Financials in millions SGD. Fiscal year is January - December.
Millions SGD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
Revenue | 71.89 | 69.99 | 62.95 | 40.47 | 36.33 | 42.87 | Upgrade
|
Revenue Growth (YoY) | 2.92% | 11.18% | 55.56% | 11.40% | -15.27% | 6.00% | Upgrade
|
Cost of Revenue | 40.42 | 38.96 | 34.19 | 22.59 | 20.27 | 22.82 | Upgrade
|
Gross Profit | 31.47 | 31.04 | 28.77 | 17.88 | 16.06 | 20.05 | Upgrade
|
Selling, General & Admin | 13.38 | 12.26 | 10.43 | 8.62 | 8.39 | 8.74 | Upgrade
|
Other Operating Expenses | 0.63 | 1.28 | 1.45 | 0.57 | 0.56 | 0.56 | Upgrade
|
Operating Expenses | 14.01 | 13.54 | 11.88 | 9.18 | 8.95 | 9.29 | Upgrade
|
Operating Income | 17.46 | 17.49 | 16.88 | 8.69 | 7.11 | 10.76 | Upgrade
|
Interest Expense | -0.65 | -0.65 | -0.56 | -0.4 | -0.42 | -0.26 | Upgrade
|
Interest & Investment Income | - | - | - | 0.22 | 0.31 | 0.5 | Upgrade
|
Earnings From Equity Investments | - | - | -0 | -0.01 | -0.02 | -0.03 | Upgrade
|
Currency Exchange Gain (Loss) | - | - | - | -0.13 | 0.03 | -0.01 | Upgrade
|
Other Non Operating Income (Expenses) | 1.42 | 0.46 | 0.44 | 0.33 | 0.31 | 0.2 | Upgrade
|
EBT Excluding Unusual Items | 18.23 | 17.3 | 16.77 | 8.7 | 7.32 | 11.15 | Upgrade
|
Merger & Restructuring Charges | - | - | - | -0.05 | - | -0.05 | Upgrade
|
Impairment of Goodwill | - | - | - | - | -1.48 | -1.18 | Upgrade
|
Gain (Loss) on Sale of Assets | - | - | - | - | 0.02 | -0 | Upgrade
|
Asset Writedown | - | - | - | -0 | - | -0.02 | Upgrade
|
Other Unusual Items | 0.01 | 0.01 | 0.01 | 0.44 | 0.66 | - | Upgrade
|
Pretax Income | 18.24 | 17.31 | 16.78 | 9.09 | 6.51 | 9.91 | Upgrade
|
Income Tax Expense | 4.23 | 4.16 | 4.05 | 2.21 | 2.06 | 2.66 | Upgrade
|
Earnings From Continuing Operations | 14.01 | 13.15 | 12.73 | 6.88 | 4.45 | 7.25 | Upgrade
|
Minority Interest in Earnings | -0.14 | -0.19 | -0.21 | 0.03 | 0.24 | 0.22 | Upgrade
|
Net Income | 13.87 | 12.96 | 12.52 | 6.91 | 4.69 | 7.47 | Upgrade
|
Net Income to Common | 13.87 | 12.96 | 12.52 | 6.91 | 4.69 | 7.47 | Upgrade
|
Net Income Growth | 3.98% | 3.54% | 81.32% | 47.23% | -37.17% | -11.20% | Upgrade
|
Shares Outstanding (Basic) | 575 | 573 | 564 | 550 | 548 | 528 | Upgrade
|
Shares Outstanding (Diluted) | 575 | 573 | 564 | 550 | 548 | 528 | Upgrade
|
Shares Change (YoY) | 0.15% | 1.73% | 2.42% | 0.52% | 3.79% | 2.03% | Upgrade
|
EPS (Basic) | 0.02 | 0.02 | 0.02 | 0.01 | 0.01 | 0.01 | Upgrade
|
EPS (Diluted) | 0.02 | 0.02 | 0.02 | 0.01 | 0.01 | 0.01 | Upgrade
|
EPS Growth | 3.84% | 1.80% | 77.60% | 45.93% | -39.25% | -13.27% | Upgrade
|
Free Cash Flow | 10.03 | 13.75 | 12.14 | 11.57 | 5.56 | 10.3 | Upgrade
|
Free Cash Flow Per Share | 0.02 | 0.02 | 0.02 | 0.02 | 0.01 | 0.02 | Upgrade
|
Dividend Per Share | 0.011 | 0.016 | 0.016 | 0.011 | 0.008 | 0.008 | Upgrade
|
Dividend Growth | -37.50% | 3.21% | 48.57% | 31.25% | 0% | -48.72% | Upgrade
|
Gross Margin | 43.78% | 44.34% | 45.70% | 44.18% | 44.20% | 46.76% | Upgrade
|
Operating Margin | 24.29% | 24.99% | 26.82% | 21.48% | 19.56% | 25.09% | Upgrade
|
Profit Margin | 19.30% | 18.52% | 19.89% | 17.06% | 12.91% | 17.41% | Upgrade
|
Free Cash Flow Margin | 13.96% | 19.65% | 19.28% | 28.58% | 15.31% | 24.03% | Upgrade
|
EBITDA | 19.55 | 19.49 | 18.58 | 10.31 | 8.79 | 12.36 | Upgrade
|
EBITDA Margin | 27.20% | 27.84% | 29.52% | 25.48% | 24.18% | 28.83% | Upgrade
|
D&A For EBITDA | 2.09 | 2 | 1.7 | 1.62 | 1.68 | 1.6 | Upgrade
|
EBIT | 17.46 | 17.49 | 16.88 | 8.69 | 7.11 | 10.76 | Upgrade
|
EBIT Margin | 24.29% | 24.99% | 26.82% | 21.48% | 19.56% | 25.09% | Upgrade
|
Effective Tax Rate | 23.17% | 24.05% | 24.14% | 24.29% | 31.59% | 26.81% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.